FDA Inspection 851665 — Merck Sharp & Dohme Corp.
The FDA completed an inspection of Merck Sharp & Dohme Corp. on September 27, 2013 in Ambler, PA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- September 27, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ambler, PA (United States)
Additional Details
Sponsor, Contract Research Organization